ethinyl estradiol; norelgestromin · Viatris Specialty · NDA 219990
Gwyn Lo
Earliest generic entry, as listed
28 Jul 2029
Blocked by exclusivity: NP.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NP | new product | 28 Jul 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 219990 · 001 · RLD | system, transdermal | 0.02MG/24HR;0.22MG/24HR | 28 Jul 2029 |